Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).

Details

Request a copyRequest a copy
Serval ID
serval:BIB_A19B2FD68BEA
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).
Journal
Vaccine
Author(s)
García F., Bernaldo de Quirós J.C., Gómez C.E., Perdiguero B., Nájera J.L., Jiménez V., García-Arriaza J., Guardo A.C., Pérez I., Díaz-Brito V., Conde M.S., González N., Alvarez A., Alcamí J., Jiménez J.L., Pich J., Arnaiz J.A., Maleno M.J., León A., Muñoz-Fernández M.A., Liljeström P., Weber J., Pantaleo G., Gatell J.M., Plana M., Esteban M.
ISSN
1873-2518 (Electronic)
ISSN-L
0264-410X
Publication state
Published
Issued date
2011
Volume
29
Number
46
Pages
8309-8316
Language
english
Notes
Publication types: Journal ArticlePublication Status: ppublish
OAI-PMH
oai:serval.unil.ch:BIB_A19B2FD68BEA
DOI
10.1016/j.vaccine.2011.08.098
Pubmed
21907749
Web of science
000296988500020
Create date
08/11/2011 17:30
Last modification date
20/08/2019 16:07
Usage data